Clinical Trial Update: GW873140 In Combination With Kaletra In HIV Infected Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial of GW873140 in combination with Kaletra for HIV infection was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• GW873140
• Kaletra (lopinavir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus I, HIV Infection | Phase 2 | Status: TERMINATED